Company
holmusk.com
Creating the standard for neuropsychiatry with best-in-class real-world evidence
Also known as Holmusk, Holmusk USA, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- Pharma, Payers, Providers, Government & Regulators, Academia
- Legal name
- Holmusk USA, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Neuropsychiatry needs better evidence to drive decision-making. There is currently no standardized way to measure symptoms or quality of care for neuropsychiatric conditions, making innovation in the field difficult to achieve.
Funding snapshot
- Total raised
- $30MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed2023-01-09
Funding rounds
- Round, 2023
- $30M2023-09-29, SEC form D sold, 1 investor
- Round, 2023
- 2023-01-09
Products
- Web
- NeuroBlu
Loading relationship preview